Back to results
US 2026/0097150 A1Published application
Implantable Device for Treating an Ocular Condition
AssigneeCelanese EVA Performance Polymers LLC
InventorsHarsh Patel, Jeffrey Haley, Cyonna Holmes
Life of this patent
Estimating the term…
Abstract
The implantable device includes a core including a core polymer matrix within which is dispersed one or more therapeutic agents. The core polymer matrix includes a hydrophobic polymer comprising a first poly ortho ester (POE) polymer. The POE polymer has a Tg of between about −20° C. and 40° C. as determined in accordance with ASTM E1640-18. Methods for treating conditions in a patient in need thereof are also provided.
Claims20
An implantable device for ocular insertion, the implantable device comprising:
- a core comprising a core polymer matrix within which is dispersed one or more therapeutic agents, wherein core polymer matrix comprises a hydrophobic polymer comprising a first poly ortho ester (POE) polymer, wherein the POE polymer has a Tg of between about −20° C. and 40° C. as determined in accordance with ASTM E1640-18.
Dependencies are inferred from the claim text.